CytomX Therapeutics (CTMX) Gains Analyst Confidence on Trial Progress
Corroborated by 1 source from 1 publisher
globalcrime2d ago
TL;DR
According to finance.yahoo.com, pixabay/Public domain Catanzaro noted that the data from CytomX’s lead drug candidate test showed dose-dependent efficacy.